Liu Ranran, Liu Jing, Song Jingyuan, Peng Ying, Jin Guoliang, Li Jinghui
School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu, China; Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu, China.
J Stroke Cerebrovasc Dis. 2025 Mar;34(3):108215. doi: 10.1016/j.jstrokecerebrovasdis.2024.108215. Epub 2024 Dec 30.
To investigate the current status and influencing factors of fear of disease progression in stroke patients, and to analyze the mediating effect of social support between symptom burden and the fear of disease progression.
A cross-sectional study recruited 235 stroke patients in a convenience sample from the neurology department of a tertiary hospital in China. The general information questionnaire, social support rating scale, stroke symptom experience scale, and fear of progression questionnaire short form were utilized for the survey. This study adheres to STROBE reporting guidelines.
The fear of disease progression score in stroke patients was 29.11 (6.72). Results from the multivariable analysis indicated that patients without a family history of stroke (β = -0.09, 95 % CI (-2.37, -0.15)), elderly patients (≥ 65) (β = -0.26, 95 % CI (-4.88, -2.32)), hypertensive patients (β = 0.10, 95 % CI (0.40, 2.63)), and patients with balanced budgets (β = -0.13, 95 % CI (-3.58, -0.28)) exhibited lower levels of fear of disease progression. Unemployment (β = 0.21, 95 % CI (1.72, 4.54)), patients experiencing heavy symptom burden (β = 0.56, 95 % CI (4.86, 6.67)), and those with low social support (β = -0.28, 95 % CI (-0.42, -0.22)) had a higher level of fear of disease progression. Social support (β = 0.14, 95 % CI (0.08, 0.20)) mediated the correlation between symptom burden and fear of disease progression.
Stroke patients have moderate to low levels of fear of disease progression. Nursing staff should provide more social support to patients with heavier symptom burdens to reduce their fear of disease progression.
Healthcare providers and caregivers can reduce the fear of disease progression in stroke patients with high symptom burden by increasing their level of social support. This study can help promote the mental health of stroke patients.
No patient or public contribution.
调查脑卒中患者疾病进展恐惧的现状及影响因素,并分析社会支持在症状负担与疾病进展恐惧之间的中介作用。
一项横断面研究在中国一家三级医院神经内科采用便利抽样法招募了235例脑卒中患者。使用一般信息问卷、社会支持评定量表、脑卒中症状体验量表和疾病进展恐惧问卷简表进行调查。本研究遵循STROBE报告指南。
脑卒中患者的疾病进展恐惧评分为29.11(6.72)。多变量分析结果表明,无脑卒中家族史的患者(β = -0.09,95%CI(-2.37,-0.15))、老年患者(≥65岁)(β = -0.26,95%CI(-4.88,-2.32))、高血压患者(β = 0.10,95%CI(0.40,2.63))和收支平衡的患者(β = -0.13,95%CI(-3.58,-0.28))疾病进展恐惧水平较低。失业(β = 0.21,95%CI(1.72,4.54))、症状负担重的患者(β = 0.56,95%CI(4.86,6.67))和社会支持低的患者(β = -0.28,95%CI(-0.42,-0.22))疾病进展恐惧水平较高。社会支持(β = 0.14,95%CI(0.08,0.20))介导了症状负担与疾病进展恐惧之间的相关性。
脑卒中患者疾病进展恐惧水平为中度至低度。护理人员应向症状负担较重的患者提供更多社会支持,以减轻其对疾病进展的恐惧。
医疗服务提供者和护理人员可通过提高社会支持水平,减轻症状负担重的脑卒中患者对疾病进展的恐惧。本研究有助于促进脑卒中患者的心理健康。
无患者或公众贡献。